Sales rise 13.60% to Rs 3076.51 crore
Net profit of Mankind Pharma rose 30.43% to Rs 653.47 crore in the quarter ended September 2024 as against Rs 501.03 crore during the previous quarter ended September 2023. Sales rose 13.60% to Rs 3076.51 crore in the quarter ended September 2024 as against Rs 2708.10 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales3076.512708.10 14 OPM %27.6325.21 -PBDT954.94737.48 29 PBT849.32640.99 33 NP653.47501.03 30Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
 "US election")
 "Apollo")
 "thomson reuters")
 "result, q1, q2, q3, q4")
 "Supreme court")
